News | Clinical Trials | August 05, 2016

New Imaging Method Could Catch Osteoarthritis Early

Emerging technology assesses bone health at microscopic level, may guide development of preventive therapies 

Osteoarthritis

A promising imaging technology that measures bone health at the microscopic level could help doctors detect osteoarthritis in its early stages and guide the development of new therapies, suggests preliminary research being presented at the 58th Annual Meeting of the American Association of Physicists in Medicine (AAPM).

“The technology we are developing allows us to see very fine detail in the mesh-like microstructure of bone — known as trabecular bone — which currently can’t be assessed in patients,” said Wojciech B. Zbijewski, Ph.D., a medical physicist and instructor in the department of biomedical engineering at Johns Hopkins University, Baltimore. “This could help us detect bone diseases in their initial stages and help with development of new preventive therapies. For example, there is growing evidence that early stages of osteoarthritis involve changes in trabecular bone, so if we can detect such change, a patient could potentially avoid painful knee replacement surgery by getting treatment before the cartilage was irreversibly damaged.”

Osteoarthritis often occurs after a joint is injured, leading to progressive damage of the cartilage that lines and cushions the joint and causing pain and stiffness.

The technology, a special cone beam computed tomography (CBCT) system using complementary metal-oxide semiconductor (CMOS) detectors provides several advantages over standard methods: the device is portable and could be used in doctors’ offices; patients could be imaged standing (vs. lying down); and the radiation dose is lower than standard computed tomography (CT). The CMOS detector provides very high spatial resolution, allowing detection of finer details than in standard CT and therefore greatly enhancing the ability to assess trabecular bone. This imaging system also could help with early identification of osteoporosis, which causes bones to become weak and brittle and break more easily.

The researchers used CBCT/CMOS to image the hand of a human cadaver, as well as pelvic bone biopsy samples from 25 living women. They determined it provided results that correlate with micro-CT, which is the gold standard for assessing trabecular bone, but can only be used for bone samples (biopsies), not living patients whose joints are too large to be scanned using this method. They anticipate beginning the first studies of CBCT/CMOS in patients late next year.

Today, joint pain often is assessed by X-ray or magnetic resonance imaging (MRI), which shows if the cartilage lining the joint has been damaged. In most cases, by the time a patient has pain, the damage to the joint is irreversible. The only permanent solution is to surgically replace that joint. Joint replacement is a common procedure: 719,000 knee replacements and 332,000 hip replacements are performed every year, according to the Centers for Disease and Prevention (CDC).

If further research supports these findings, in the future a person who injures a joint — for example by breaking a bone or tearing a ligament — could be scanned using this technology to assess the bone health immediately after the injury and during treatment. Current prevention methods include losing weight, doing exercises that don’t stress the joint (such as swimming and biking) and taking supplements such as vitamin D and calcium. This technology also could be used by researchers to guide development of treatments to prevent bone damage, said Zbijewski.

In addition to Zbijewski, collaborators on the study being presented at AAPM include: Qian Cao, Alejandro Sisniega, Michael Brehler, J. Webster Stayman, Jeffrey Siewerdsen, Eugenio Marinetto, and John Yorkston. The research was made possible through a grant from the National Institutes of Health.

For more information: www.aapm.org

Related Content

The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Sponsored Content | Case Study | Computed Tomography (CT) | November 06, 2018
The following is a summary of a study published in the
The NeuViz 16 Essence from Neusoft Medical Systems.

The NeuViz 16 Essence from Neusoft Medical Systems.

Feature | Computed Tomography (CT) | November 05, 2018 | By Melinda Taschetta-Millane
According to an industry mark...
Deaconess Health System Chooses Sectra as Enterprise Imaging Vendor
News | Enterprise Imaging | November 02, 2018
International medical imaging information technology (IT) and cybersecurity company Sectra will install its enterprise...
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more